SEEDPG
TMO icon

S.E.E.D. Planning Group’s Thermo Fisher Scientific TMO Stock Holding History

S.E.E.D. Planning Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.7M Sell
23,215
-4,059
-15% -$2.41M 3.84% 6
2026
Q2 		$13.7M Buy
27,274
+1,444
+6% +$693K 3.61% 8
2026
Q1 		$12.7M Sell
25,830
-377
-1% -$205K 3.69% 9
2025
Q4 		$15.2M Sell
26,207
-1,248
-5% -$706K 4.33% 5
2025
Q3 		$13.3M Sell
27,455
-786
-3% -$366K 3.88% 6
2025
Q2 		$11.5M Buy
28,241
+17,267
+157% +$7.22M 3.59% 10
2025
Q1 		$5.46M Buy
10,974
+348
+3% +$188K 1.84% 25
2024
Q4 		$5.53M Buy
10,626
+618
+6% +$340K 1.85% 19
2024
Q3 		$6.19M Sell
10,008
-127
-1% -$75.2K 2.05% 18
2024
Q2 		$5.6M Sell
10,135
-43
-0.4% -$24.6K 2.04% 20
2024
Q1 		$5.92M Buy
10,178
+371
+4% +$208K 2.16% 19
2023
Q4 		$5.21M Buy
9,807
+503
+5% +$243K 2.1% 18
2023
Q3 		$4.71M Buy
9,304
+302
+3% +$161K 1.82% 23
2023
Q2 		$4.7M Buy
9,002
+198
+2% +$107K 1.65% 28
2023
Q1 		$5.07M Buy
8,804
+855
+11% +$482K 1.96% 21
2022
Q4 		$4.38M Buy
7,949
+1,489
+23% +$789K 1.9% 27
2022
Q3 		$3.28M Buy
6,460
+773
+14% +$433K 1.53% 31
2022
Q2 		$3.09M Buy
5,687
+3,064
+117% +$1.69M 1.4% 33
2022
Q1 		$1.55M Buy
2,623
+27
+1% +$15.5K 0.66% 42
2021
Q4 		$1.73M Sell
2,596
-232
-8% -$145K 0.75% 40
2021
Q3 		$1.62M Sell
2,828
-202
-7% -$111K 0.76% 40
2021
Q2 		$1.53M Buy
3,030
+573
+23% +$270K 0.75% 37
2021
Q1 		$1.12M Buy
+2,457
New +$1.17M 0.62% 39

Other funds holding TMO

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Guyasuta Investment Advisors
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return
Caledonia Investments plc (UK)
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

S.E.E.D. Planning Group's TMO Position: Q3 2026 in Review

S.E.E.D. Planning Group reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q3 2026, selling an estimated $2.41M and leaving 23,215 shares worth $15.7M. The position accounts for 3.84% of the portfolio, ranked #6.

S.E.E.D. Planning Group first reported a position in TMO in Q1 2021 and has held it in 23 quarters since. 486 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • S.E.E.D. Planning Group held 23,215 shares of Thermo Fisher Scientific worth $15.7M as of Q3 2026.
  • S.E.E.D. Planning Group sold 4,059 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.41M.
  • Thermo Fisher Scientific made up 3.84% of S.E.E.D. Planning Group's portfolio in Q3 2026, its #6 holding.
  • S.E.E.D. Planning Group first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 23 quarters since.
  • 486 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on S.E.E.D. Planning Group's 13F filing for Q3 2026, filed 7 Oct 2026.